TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL

• 收藏
• 分享

专利权人:

INC.;ZYNERBA PHARMACEUTICALS

发明人:

Terri Sebree,Donna Gutterman

申请号：

US16712066

公开号：

US20200188324A1

申请日:

2019.12.12

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present technology relates to methods of treating one or more behavioral symptoms (for example, anxiety) of 22q11.2 deletion syndrome in a subject by administering, e.g., transdermally, an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of 22q11.2 deletion syndrome are treated in the subject

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/